NLRP14 antibody
Principal name
NLRP14 antibody
Alternative names for NLRP14 antibody
NALP14, NOD5, NACHT LRR and PYD domains-containing protein 14, Nucleotide-binding oligomerization domain protein 5
Gene ID
338323 (NLRP14)
Ncbi ID
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Paraffin Sections (P), Western blot / Immunoblot (WB)
Background of NLRP14 antibody
NALP proteins are cytoplasmic proteins that form a subfamily within the larger CATERPILLER family and are thought to play a crucial role in cell proliferation and reproduction. Like all other NALP family members, NALP14 has a C-terminal leucine-rich repeat (LRR) region, an N-terminal Pyrin domain (PYD) followed by a NACHT domain, and a NACHT-associated domain. While little is known about the function of NALP14, it has been suggested that it may play a role in spermatogenesis and that mutations in the NALP14 gene might cause spermatogenic failure.
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA320168 | NLRP14 (N-term) antibody |
||||||
| Rabbit Polyclonal NALP14 Antibody | |||||||
 |
Rabbit | Aff - Purified | Hu, Ms, Rt | E, WB |
0.1 mg /
€415.00
|
||
| OriGene Technologies, Inc. | |||||||
| AP31238PU-N | NLRP14 (N-term) antibody |
||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | E, P, WB |
50 µg /
€425.00
|
|
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY406110 | NLRP14 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. |
Human Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| RC215050L2V | Lenti ORF particles, NLRP14 (mGFP-tagged) - Human NLR family, pyrin domain containing 14 (NLRP14), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,330.00
|
|
| OriGene Technologies, Inc. | ||
| RC215050L1V | Lenti ORF particles, NLRP14 (Myc-DDK tagged) - Human NLR family, pyrin domain containing 14 (NLRP14) , 200 uL, >10^7 TU/mL |
|
|
200 µl /
€2,100.00
|
|
| OriGene Technologies, Inc. | ||